Episode Details
Back to EpisodesEpisode 12: Unveiling the T-Vant Adjuvant with Key Opinion Leaders Lisa Morici and James McLachlan
Season 1
Episode 12
Published 3 years, 2 months ago
Description
Vaccine adjuvants are integral to for vaccines to generate an immune response. On this episode, Lisa Morici, PhD, and James McLachlan, PhD, discuss their new vaccine adjuvant, T-Vant, and its differences from other adjuvants. They also walk through the history and benefits of their adjuvant's outer membrane vesicle technology and the landscape of vaccines in the present day. Episode hosted by Elaine Hamm, PhD.
Links:
Connect with Lisa Morici, PhD, and James McLachlan, PhD.
Connect with Elaine Hamm, PhD.
Learn about Tulane Medicine Business Development and the School of Medicine.
Check out BIO on the BAYOU and make plans to attend in October, 2023.
Learn more about BIO from the BAYOU – the show, the upcoming event, and more!
Learn more about podcast sponsor, The XLerator Network.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
Links:
Connect with Lisa Morici, PhD, and James McLachlan, PhD.
Connect with Elaine Hamm, PhD.
Learn about Tulane Medicine Business Development and the School of Medicine.
Check out BIO on the BAYOU and make plans to attend in October, 2023.
Learn more about BIO from the BAYOU – the show, the upcoming event, and more!
Learn more about podcast sponsor, The XLerator Network.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.